CNS pipeline · person

Amy Kruse, PhD

Member of the Board of Directors of Gilgamesh Pharmaceuticals. Neuroscientist and venture investor; General Partner at Prime Movers Lab (lead investor in Gilgamesh's Series A) and a former program manager at DARPA.

  • 1 company

Current roles

Appears with

People sharing a company with Amy.

People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.